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Asthma in the elderly is often underrecognized and suboptimally treated, resulting in an
increased morbidity and mortality. The characteristics of asthma-related bronchitis and its
optimal treatment remain to be determined in this population. We aimed to compare lung
function and airway inflammation in elderly and younger asthmatic subjects.
Data from two induced sputum databases were analyzed in three groups of asthmatic
subjects (18e30 y, n Z 136; 31e59 y, n Z 385; 60e72 y, n Z 172) and one group of healthy
elderly subjects (60e89 y, n Z 16). Expiratory flows and induced sputum cell counts were
analyzed.
Airway obstruction was more marked in elderly asthmatics compared with healthy elderly or
younger asthmatic subjects (p < 0.01). An increase in sputum neutrophils and a decrease in
macrophages and lymphocytes were observed in elderly asthmatics (p < 0.0001). Neutrophil
percentages significantly increased with asthma severity in the young and the middle-aged
groups, while they remained similar in elderly asthmatics regardless of asthma severity
(p < 0.05). Neutrophil percentages weakly correlated with the dose of ICS in all asthmatics
(r Z 0.17, p < 0.0001). Age and dose of ICS were independent predictors of neutrophil
percentage in asthmatic subjects in a regression model (R2 Z 0.12). Asthma in the elderly is
associated with a more marked airway obstruction and sputum neutrophilia. Both age and
the dose of corticosteroids need to be considered in the interpretation of the clinical relevance
of sputum neutrophil count.
ª 2011 Elsevier Ltd. All rights reserved.8 656 4747; fax: þ1 418 656 4762.
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Although most studies on asthma have been performed on
young ormiddle-aged populations, 6e10% of elderly patients
have asthma.1 Asthma in the aged patient may have devel-
oped early in life, but it may also be of late-onset, beginning
late in life, without past history of atopic or respiratory
disease.2 Elderly patients are responsible for a large
proportionof hospitalizations due toasthma, associatedwith
substantial health care costs.3 Most guidelines do not specify
if the management and treatment should be different in the
elderly compared to the younger asthmatics, and current
recommendations are based on studies conducted in younger
patients with asthma.
Airway function of asthmatic patients has been shown to
decline at a faster rate than in normal subjects.4 Typical
asthma symptoms, such as wheezing and chest tightness,
may be absent in older asthmatic patients.5 Bronchopro-
vocation studies have shown that increased airway resis-
tance is poorly perceived by older people.6 Moreover,
distinguishing between asthma and chronic obstructive
pulmonary disease (COPD) may be difficult in the elderly.
Marsh et al. showed that 55% of COPD subjects also have
asthma.7 In older patients, the frequently associated co-
morbidities can induce symptoms considered falsely to be
due to asthma, or can worsen the asthmatic condition. All
these reasons, among others, may explain the under-
diagnosis and undertreatment of asthma in older patients.8
However, there is also a possibility that asthma in the
elderly presents a different phenotype, less responsive to
current therapies. This is supported by previous observations
of a lesser response to corticosteroids in this population,9
although the mechanisms underlying such reduced
response remain to be documented. To our knowledge, no
study has yet compared respective physiological and
inflammatory changes in elderly asthmatic patients
compared to younger populations. In this study, we investi-
gated the alterations in pulmonary function and changes in
airway inflammatory features of elderly asthmatic patients.
Methods
A retrospective analysis of two large induced sputum
databases from the Institut de cardiologie et de pneumo-
logie de Que´bec and McMaster University was done. A total
of 693 patients with stable asthma who had sputum cell
counts and spirometry performed at our institutions
between September 1999 and June 2008 were included in
the analysis. Both centers were using the same procedures.
Asthmatic subjects were divided in three different age
groups: young (18e30 y, n Z 136), middle-aged (31e59 y,
n Z 385), and elderly (60e72 y, n Z 172). A control group
of healthy elderly subjects (60e89 y; n Z 16) was also
included in the study. All subjects had no respiratory
infection 4 weeks preceding their visit and were able to
produce sputum. Asthma severity was determined accord-
ing to the Canadian consensus guidelines, mostly based on
medication needs to control asthma.10 Current smokers and
ex-smokers with a tobacco history of more than 10 pack-
years were excluded. When that data was not available,
subjects were excluded when “smokers’ inclusions” weredetected in sputum macrophages.11 Sputum was induced
and processed according to the methods described by Piz-
zichini et al.12 Analyses of forced expiratory volume in 1 s
(FEV1) post bronchodilator (BD), forced vital capacity (FVC)
post BD, and inflammatory cell counts (neutrophils, eosin-
ophils, lymphocytes, and macrophages) were conducted.
We analyzed the different inflammatory phenotypes in
each group of subjects. Based on the normal range values
published by Belda et al.13 and Spanevello et al.14, we
defined an eosinophilic phenotype as a sputum eosinophil
percentage greater than 2.2%, a neutrophil phenotype as
a percentage greater than 64.4%, a mixed phenotype when
both eosinophils and neutrophils were above those limits,
and a paucigranulocytic phenotype when cell percentages
were in the normal range.
Other data collected at the time of sputum induction
included the confirmation of a diagnosis of asthma by
a respirologist and the dose of inhaled or oral asthma
medication. The diagnosis of asthma was based on
a compatible clinical history with evidences of reversible
airflow limitation (bronchodilator reversibility of 12% or
more or a provocative dose of methacholine inducing a 20%
fall in FEV1 (PC20 < 8 mg/ml)). The protocol was reviewed
and approved by the local Institutional Ethics Committee.
Statistical analyzes
Data were expressed using mean  SD/SEM or median
[interquartile range]. The two-way ANOVA was used to
analyse data. Two experimental factors, one associated to
the comparison among age categories (18e30 years, 31e59
years, 60e72 years (asthmatic and control group)), factor
fixed, and one associated to the comparison among the
different asthma severities (mild, moderate, severe or
healthy), factor fixed, with interaction terms between the
fixed factors were defined. Variables expressed in
percentage were analyzed using the sin1(O) trans-
formation. Cell counts data were analyzed using the log
transformation to stabilize variances. In situationswhere the
normality assumptions were unjustified after log trans-
formation, the alternative procedure used was the rank
transformation using the ordinary F test from the two-way
ANOVA (non-parametric analyses). Reported p-values are
based on these transformations. For variables using para-
metric analyses, the variance assumptions were verified
using the Brown and Forsythe’s variation of Levene’s test
statistic and the univariate normality assumptions were
verified with the ShapiroeWilk tests. Correlations between
continuous variables were expressed using the Pearson’s
correlation coefficients. One-way ANOVA was used to
compare asthma severity groups based on neutrophil values.
The results were considered significant with p-values0.05.
All analyses were conducted using the statistical package
SAS, version 9.1.3 (SAS Institute Inc, Cary, NC, USA.).
Results
Data from 693 asthmatic patients and 16 healthy elderly
controls were analyzed. Characteristics of patients are
shown in Table 1. FEV1, FVC, and FEV1/FVC ratio were
significantly lower in the elderly asthmatic group compared
Table 1 Characteristics of study participants.
Groups Young
Asthmatics (18e30 y)
Middle-aged
Asthmatics (31e59 y)
Elderly
Asthmatics (60e72 y)
Healthy
Elderly (60e89 y)
n 136 385 172 16
Mild asthmatics 84 169 59 e
Moderate asthmatics 33 125 70 e
Severe asthmatics 19 91 43 e
Age (years) 24  4* 47  8* 65  4* 74  9y
Sex (F/M) 90/46 210/175 90/82 9/7
FEV1 (% predicted) 97  20* 81  24* 69  23* 95  12þ
FVC (% predicted) 103  18* 92  19* 84  20* 96  15**
FEV1/FVC (%) 80  10* 71  12* 65  13* 76  7**
ICS (mg) 423  470* 565  497 633  471 N/A
Mean  SD; FEV1: Forced expiratory volume in 1 s; FVC: Forced vital capacity; ICS: Inhaled corticosteroids (fluticasone equivalent, daily
mg). *p < 0.05 vs the two other asthmatic groups. **p < 0.01 vs the elderly asthmatic group. yp < 0.01 vs the three asthmatic groups.
þp < 0.001 vs middle-aged and elderly asthmatic groups.
1286 M.-E. Ducharme et al.with the control, middle-aged, and young asthmatic
groups. Younger subjects were taking less ICS than middle-
aged and elderly subjects.
Inflammatory cell counts are shown in Table 2. Sputum
neutrophil percentages and absolute numbers were higher
and macrophage and lymphocyte percentages were lower
in the elderly asthmatics compared with the middle-aged
and the young asthmatic groups. When analyzing all asth-
matic subjects together, age and sputum neutrophil
percentages were correlated (r Z 0.38, p < 0.001). When
analyzing data according to asthma severity, as determined
by the Canadian guidelines,10 neutrophil percentages
significantly increased with asthma severity in the young
and the middle-aged groups, while they remained similar in
elderly asthmatics regardless of asthma severity (Fig. 1).
Age and neutrophil percentages correlated in mild
(r Z 0.44, p < 0.0001) and moderate (r Z 0.28,
p < 0.0001), but not in severe asthmatics (r Z 0.16,
p Z 0.10).
We also looked at the different inflammatory pheno-
types in each group of subjects. We found that 62% of
elderly subjects had a neutrophilic or mixed phenotype,
compared with 37% in the middle-aged and 21% in the young
group (p < 0.0001, Fig. 2). The majority of younger subjectsTable 2 Sputum cell counts according to age groups.
Groups Young
Asthmatics (18e30 y)
Middle-
Asthma
n 136 385
TCC (106 cells/g) 3.05 [4.75] 3.80 [6.
Neutrophils (%) 27.0 [40.6]* 52.5 [45
Eosinophils (%) 0.8 [3.8] 0.8 [4.3
Lymphocytes (%) 1.0 [2.0]* 0.7 [1.7
Macrophages (%) 63.9 [43.2]* 36.7 [39
Neutrophils (106 cells/g) 0.74 [2.24]* 1.64 [5.
Eosinophils (106 cells/g) 0.02 [0.12] 0.04 [0.
Lymphocytes (106 cells/g) 0.03 [0.07] 0.02 [0.
Macrophages (106 cells/g) 1.40 [2.05] 1.35 [1.
Median [interquartile range]; TCC: Total cell count; *p< 0.01 vs the two(53%) had no airway inflammation, while it was the case for
only 19% of elderly patients. The type of inflammation was
not associated with asthma severity in elderly subjects
(p > 0.05, Fig. 3).
A sub-analysis (n Z 554) showed that daily ICS dose and
neutrophil percentages were weakly correlated in all
subjects (r Z 0.15, p Z 0.0003). Neutrophil percentages
were weakly correlated with the dose of ICS in mild
(r Z 0.15, p Z 0.02), but not in moderate (r Z 0.04,
p > 0.05) or severe asthmatics (r Z 0.11, p > 0.05).
We then performed a regression analysis in all subjects
with neutrophil percentage as the dependent variable and
ICS dose and age together as predictors. Both age
(p < 0.0001) and ICS dose (pZ 0.003) remained significant
in the model, suggesting that they are independent
predictors of neutrophil percentage (R2 Z 0.12, Table 3).
That relation was not present in the elderly group alone.Discussion
In this study, we examined the lung function and sputum
inflammatory cells in young, middle-aged, and elderly
asthmatic subjects to determine whether age could affectaged
tics (31e59 y)
Elderly
Asthmatics (60e72 y)
Healthy
Elderly (60e89 y)
172 16
70]** 5.65 [9.73] 4.30 [4.30]
.4]* 72.9 [34.3]* 65.6 [21.3]**
] 1.0 [4.6] 0.7 [1.8]
]* 0.5 [1.1]* 0.9 [1.3]
.9]* 19.5 [24.0]* 30.8 [25.5]**
00]* 3.94 [8.14]* 2.75 [3.46]
21] 0.04 [0.37]* 0.02 [0.12]
08] 0.03 [0.08] 0.03 [0.13]
84] 1.11 [1.63]* 1.39 [1.29]
other asthmatic groups; **p< 0.0001 vs the young asthmatic group.
Figure 1 Neutrophil percentages according to asthma
severity in young (18e30 y), middle-aged (31e59 y), and
elderly (60e72 y) asthmatic and healthy (60e89 y) subjects.
Mean  SEM, )p < 0.05 vs the two other severity categories.
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obstruction and inflammation. FEV1, FVC, and FEV1/FVC
ratio were significantly lower in the elderly group compared
with the middle-aged and the young asthmatic groups. An
increase in neutrophils and a decrease in macrophages and
lymphocytes were observed in the induced sputum of
elderly asthmatics.Figure 2 Inflammatory phenotypes of each group. Paucigranuloc
Eosinophils < 2.2% and Neutrophils > 64.4%; Eosinophilic: Eosinoph
and Neutrophils > 64.4%; p < 0.0001.Our findings are consistent with previous studies showing
a decline in FEV1 with aging, in asthmatics. Lange et al.
4
published a 15-year follow-up study on lung function in
adults with asthma and observed a faster deterioration of
FEV1 in asthmatic than in healthy subjects. Furthermore,
Cassino et al.15 showed that in non-smoking elderly asth-
matics, FEV1 was significantly lower in long-standing
asthma compared with late-onset asthma, confirming
a link between pulmonary function decline and disease
duration, this decline in FEV1 increasing with age. Such
accelerated decline of respiratory function may be related
to the possibility that asthma is diagnosed when the illness
is already severe, due to the previously described reduction
in symptoms perception in elderly asthmatic patients.6 It
may also be due to suboptimal treatment or management.6
No data on asthma duration was available in our study so we
could not assess this parameter.
It has been suggested that neutrophilic airway inflam-
mation plays a role in the progression of persistent airflow
limitation in adult asthma.16 Neutrophils were significantly
higher in the airways of the elderly group, and a neutro-
philic phenotype was more frequently observed in these
subjects than in the younger ones. These results suggest
a change in the inflammatory cells phenotype in aging
asthma. A recent report by Nyenhuis et al. on a small
number of subjects also showed that neutrophil percent-
ages were higher in the elderly compared with young
subjects.17 This study, however, did not include a healthyytic: Eosinophils < 2.2% and Neutrophils < 64.4%; Neutrophilic:
ils > 2.2% and Neutrophils < 64.4%; Mixed: Eosinophils > 2.2%
Figure 3 Inflammatory phenotypes according to asthma
severity in the elderly group. p > 0.05.
1288 M.-E. Ducharme et al.control group. Vignola et al.18 evaluated induced sputum
samples from elderly asthmatic subjects and found that the
number of neutrophils significantly correlated with the
levels of both active and total elastase, which were both
higher than in control non-asthmatic subjects. Neutrophils
release oxygen free radicals, cytokines, and a wide variety
of enzymes, including elastase, which may affect bronchial
epithelium by degrading elastin and other extracellular
matrix proteins.19 This neutrophilic inflammation could
cause airway damage and amplify the decrease of lung
function in elderly asthmatics.
Thomas et al.20 showed that sputum neutrophil counts
increase with age in normal healthy adults. Our sub-analysis
on 16 healthy elderly subjects showed an elevated
percentage of neutrophils while pulmonary function
remained normal. Neutrophil percentages and numbers
were not statistically different than elderly asthmatic
subjects. These findings suggest that high neutrophil levels
may not be specific to asthmatic patients. The effect of age
is therefore important for the interpretation of sputum
differential cell counts in older subjects.
When considering the severity of asthma, the correla-
tion between age and neutrophil counts was stronger for
mild, lesser for moderate, and nonexistent in severe
asthmatics. A regression analysis showed that both age
and ICS were independent predictors of neutrophil
percentage in all asthmatic subjects. This suggests that
the neutrophilia observed can be influenced by age, but
also by the ICS dose. This is in keeping with a recent study
by Cowan and coworkers showing that ICS intake
contributes to increased neutrophilia in asthmatic
subjects.21 Intake of inhaled corticosteroids may indeed
have influenced the results and induced neutrophilia,Table 3 Regression analysis. Neutrophil percentages (dependan
subjects.
Variable Coefficient Standard error
Intercept 22.495 4.020
Age 0.581 0.079
ICS dose 0.007 0.002
ICS: Inhaled corticosteroids; R2 Z 0.12.particularly if taken at high doses, possibly by preventing
neutrophil apoptosis.22
One of the key observations of this analysis is indeed the
fact that neutrophilia increased with age and is similar in
asthma vs controls in the elderly, while in younger patients,
only severe asthmatics had elevated neutrophils. High
doses of ICS may also induce neutrophilia. There was no
relationship between severity of asthma and neutrophilia in
the elderly, contrarily to younger asthmatic patients.
Having said that, this does not preclude the possibility that
neutrophilia does alter treatment response and clinical
outcomes in elderly asthmatics. That feature has also been
observed in the smoking population, where they are more
resistant to treatment and have increased asthma-related
morbidity. However, the results of this current study cannot
provide answers in regard to the clinical outcomes of these
patients. Another study would be needed to look at the
possibility that such change in airway inflammation
phenotype can influence diagnosis or change the clinical
response to treatment and accelerate the decline in
pulmonary function.
The response to asthma treatment is possibly reduced in
elderly patients due to the alteration of the lung structure,
including a more fixed component of airway obstruction and
reduced lung elastic recoil.23,24 It is also possible that it
could be related to a different type of inflammation
present in the airways of elderly patients. The presence of
a neutrophilic inflammation may explain why patients are
less responsive to corticosteroids. However, in our study,
eosinophil percentages were similar between age groups,
suggesting that elderly asthmatics also have a target on
which ICS can act.
There are some intrinsic limitations that need to be
acknowledged regarding the present study. Those include
the retrospective analysis, the possibility (although
unlikely) that some patients may have had a component of
COPD, and the lack of data on complete smoking history
for some patients. In that case, tobacco exposure was
inferred from the presence of smoker’s inclusions in
macrophages, which can be considered reliable.11 Further,
the measurements represent a snapshot profile of bron-
chitis which can change over time in an individual
patient.25 Thus, a prospective longitudinal study is neces-
sary to observe if persistent neutrophilic bronchitis can
lead to progressive airflow limitation. Asthma and COPD
are both components of obstructive airway diseases.26 It is
likely that persistent untreated neutrophilic bronchitis
may have contributed to the chronic airflow limitation in
elderly asthmatics.t variable) vs age and ICS dose (independant variables) in all
Standard coefficient t-value p-value
22.495 5.595 <0.0001
0.298 7.346 <0.0001
0.122 3.007 0.0028
Lung function and inflammation in elderly asthmatics 1289Conclusion
Our data suggest that elderly asthmatic subjects have
a more severe airway obstruction and airway neutrophilia
than younger patients. This neutrophilia could be attrib-
uted in part to aging and ICS intake, although the effect of
age is more dominant than the dose of ICS in elderly
subjects. More studies are needed to better characterize
these patients in order to determine the best asthma
management plan in this population.
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